Cargando…
Dexamethasone in severe COVID-19 infection: A case series
Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.
Autores principales: | Hassan, Mohamed Eliwa, Hasan, Hasan MSN., Sridharan, Kannan, Elkady, Adel, ElSeirafi, Mohamed MA. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452843/ https://www.ncbi.nlm.nih.gov/pubmed/32874905 http://dx.doi.org/10.1016/j.rmcr.2020.101205 |
Ejemplares similares
-
Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
por: ElSeirafi, Mohamed M, et al.
Publicado: (2020) -
Acute kidney injury in critically ill adults: A cross-sectional study
por: ElSeirafi, Mohamed M. A., et al.
Publicado: (2022) -
Dexamethasone for treatment of severe COVID-19, a surprise?
por: Elsayed, Hany Hasan
Publicado: (2020) -
Thyroid disease and covid‐19 infection: Case series
por: Allam, Magdy Mohamed, et al.
Publicado: (2021) -
Dexamethasone enhances risk of herpes zoster in severe COVID-19 infection
por: Price, Nathan B., et al.
Publicado: (2021)